Multiply Labs
Multiply Labs builds robotics for pharmaceutical and cell-therapy manufacturing. Its systems manipulate existing laboratory equipment to automate operations that still require substantial manual handling.
Why Global58 noticed them
Multiply Labs tackles the manufacturing dependency behind medical discovery. Its choice to automate existing equipment has published experimental support, while complete workflow validation, deployment scale and customer economics remain open.
AI can discover drugs. Multiply Labs wants robots to manufacture them.
A medicine is not finished when a promising molecule or cell therapy is discovered. Multiply Labs is building robots around the delicate physical work between a scientific idea and repeatable production.
